Document Detail

Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion.
MedLine Citation:
PMID:  23075998     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Heart failure (HF) is defined as the incapability of the heart to serve the tissues adequately with blood. This includes changes in microvascular perfusion. A mechanism aggravating perfusion disturbances in HF is endothelial dysfunction by reduced bioavailability of nitric oxide (NO). A mechanism possibly contributing to low NO bioavailability is the upregulation of arginase. Therefore, we investigated circulating arginase levels in patients with HF and its consequences for microvascular perfusion.
METHODS: A first group consisted of eighty patients with chronic HF. Patients were characterized by echocardiography and laboratory values. Arginase 1 levels were determined using a commercially available ELISA. A second experimental group included eight patients with severe heart failure. Using sidestream darkfield intravital microscopy sublingual microcirculation was quantified before and after the topical incubation of nor-NOHA as arginase inhibitor and L-NMMA as NO synthase inhibitor.
RESULTS: Circulating arginase-1 levels were significantly higher in patients with heart failure compared to controls (p < 0.001). Patients with severe heart failure (NYHA III/IV) had significantly higher arginase-1 levels compared to patients with mild heart failure (p < 0.01, NYHA I/II). Sublingual perfused capillary density increased significantly (p < 0.01) following incubation with nor-NOHA. However, this effect was abolished when nor-NOHA was co-incubated with L-NMMA.
CONCLUSIONS: In conclusion, circulating arginase 1 levels are elevated in patients with HF. A topical inhibition of arginase in these patients leads to improved microcirculation by a NO dependent mechanism. Inhibition of arginase is a possible therapeutic target to rescue microcirculation in patients with HF.
Felix Quitter; Hans R Figulla; Markus Ferrari; John Pernow; Christian Jung
Related Documents :
16600498 - Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor n...
20921238 - Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multi...
3329958 - Ventriculojugular shunt against the direction of blood flow. iii. operative technique a...
20455868 - Macrophage colony-stimulating factor (m-csf) in plasma and csf of patients with mild co...
926848 - Tension myalgia of the pelvic floor.
24119148 - Glomerular filtration rate is an independent factor of mortality in patients with decom...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical hemorheology and microcirculation     Volume:  54     ISSN:  1875-8622     ISO Abbreviation:  Clin. Hemorheol. Microcirc.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-05-30     Completed Date:  2014-05-06     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  9709206     Medline TA:  Clin Hemorheol Microcirc     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  75-85     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arginase / blood*
Heart Failure / blood*,  ultrasonography
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluorescence and two-photon absorption of push-pull aryl(bi)thiophenes: structure-property relations...
Next Document:  Nitric oxide generated by red blood cells following exposure to shear stress dilates isolated small ...